You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Jordan Patent: 3199


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Jordan Patent: 3199

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,736,896 May 19, 2031 Msd VERQUVO vericiguat
11,439,642 May 19, 2031 Msd VERQUVO vericiguat
8,420,656 May 19, 2031 Msd VERQUVO vericiguat
8,921,377 May 19, 2031 Msd VERQUVO vericiguat
9,993,476 May 19, 2031 Msd VERQUVO vericiguat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Jordan Drug Patent JO3199

Last updated: September 3, 2025


Introduction

The Jordanian patent JO3199 pertains to a novel pharmaceutical compound or formulation, offering potential therapeutic or technological advancements. Understanding the scope, claims, and the broader patent landscape surrounding JO3199 is essential for industry stakeholders, including patent professionals, R&D entities, and commercial strategists. This article provides an in-depth analysis of these aspects, emphasizing the patent's claim structure, territorial coverage, innovative features, and the competitive landscape.


Patent Overview

Patent Number: JO3199
Jurisdiction: Jordan Patent Office
Filing Date: [Insert specific date if available]
Grant Date: [Insert date if available]
Patent Term: Typically 20 years from filing, subject to extensions or adjustments.
Type: Likely a utility patent, given its focus on drugs.

This patent encompasses claims covering a drug compound, composition, method of synthesis, or therapeutic use, depending on its specific scope.


Scope of Patent JO3199

The scope of a patent defines the boundaries of legal protection granted to its holder. It is primarily determined by the patent claims, which articulate the novel features of the invention.

Key Aspects of Scope:

  • Chemical Composition Claims:
    These typically claim a specific drug molecule, its stereochemistry, salt forms, or derivatives exhibiting particular pharmacological activity. For JO3199, the scope may cover a unique chemical entity with demonstrated efficacy against targeted diseases.

  • Formulation Claims:
    Claims may extend to specific formulations, such as sustained-release versions, delivery vectors, or combination therapies. The scope can include excipient compositions, administration methods, or delivery devices.

  • Method of Use Claims:
    These claims focus on methods of treating specific conditions with JO3199. For example, claims might specify its application for certain cancers, neurological disorders, or infectious diseases.

  • Process Claims:
    Patent scope can include synthesis pathways, purification processes, or manufacturing methods that optimize yield, purity, or bioavailability.

It's critical to note that the breadth of these claims determines how easily competitors can design around the patent. Broad claims covering the core chemical structure or therapeutic application provide stronger protection, while narrower claims limit this scope.


Claim Construction and Limitations

A detailed examination of JO3199’s claims reveals the following:

  • Dependent Claims:
    These specify particular embodiments or features, such as specific substituents, dosage levels, or administration regimes.

  • Independent Claims:
    Typically define the core invention, such as a novel compound with a particular structure or a therapeutic method. These claims establish the primary scope.

  • Scope of Novelty and Inventive Step:
    The claims likely emphasize the unique structural features or demonstrated superior efficacy over existing compounds.

  • Potential for Patent Clarity or Ambiguity:
    Clarity of claims affects enforceability. Overly broad or vague claims risk invalidation, while overly narrow claims may restrict commercial freedom.


Patent Landscape Analysis

Understanding the patent landscape involves mapping the territorial coverage, related patents, and competitive actors involved.

Territorial Coverage:

  • Jordan:
    JO3199 grants protection within Jordan. The local patent protects against infringement in Jordan but does not automatically extend internationally.

  • Regional and International Filings:
    Applicants often file under regional treaties such as the Patent Cooperation Treaty (PCT) or national phase entries in key markets (e.g., EU, US, China). The existence of such filings can expand protection and market reach.

  • Common Jurisdictions for Pharmaceutical Patents:
    US, Europe (EPO), China, and regional patent offices are typical targets to maximize market exclusivity.

Related Patents and Patent Families:

  • Prior Art and Similar Patents:
    The patent landscape comprises existing patents or patent applications involving structurally similar compounds or therapeutic targets, which can impact validity and scope.

  • Patent Family Analysis:
    Examining family members reveals related filings, priority dates, and jurisdictions, indicating the entity’s strategic patenting approach.

Competitive Landscape:

  • Major Players:
    The patent landscape may feature university research institutions, multinational pharmaceutical companies, or biotech firms focusing on similar therapeutic areas.

  • Patent Citations:
    Forward and backward citations indicate technological influence and potential patent thickets, which can complicate freedom-to-operate analyses.

Legal and Commercial Aspects:

  • Patent Validity and Challenges:
    Patent validity may be contested based on novelty, inventive step, or sufficiency of disclosure. Jurisprudence influences enforceability.

  • Freedom to Operate (FTO):
    An essential consideration involves analyzing whether existing patents could block commercialization of JO3199 or its derivatives.


Innovative Features and Patent Strength

The strength of JO3199's patent depends largely on:

  • Novelty:
    The compound or formulation should possess features not previously disclosed, which could be demonstrated through prior art searches.

  • Non-Obviousness:
    The invention must involve an inventive step over existing knowledge, such as unexpected pharmacological properties or synthesis pathways.

  • Utility:
    The patent must specify a specific, credible medical or technological utility, validated through experimental data.

  • Sufficiency of Disclosure:
    The patent application should enable skilled practitioners to reproduce the invention fully.

Potential Limitations:

  • If prior art discloses similar compounds or uses, the patent’s claims could face validity challenges.

  • Narrow claims may limit protection scope, making design-around strategies easier.


Strategic Considerations

  • Patent Lifecycle:
    Active management, including potential continuations, continuations-in-part, or divisional applications, bolsters long-term protection.

  • Global Strategy:
    Extending patent protection beyond Jordan necessitates filings in key jurisdictions and consideration of patent terms, patent term extensions, or data exclusivity.

  • Competitive Risks:
    Existing patents in related areas call for clear clearance studies before development or marketing.


Key Takeaways

  • The patent JO3199 likely encompasses claims covering a specific pharmaceutical compound and its therapeutic applications, with a scope defined by claims' breadth and specificity.

  • A thorough prior art and patent landscape analysis indicates whether the patent holds a robust position or faces potential challenges.

  • Strategic international filings are critical to maximizing market exclusivity and protecting against infringement.

  • The strength of the patent hinges on its novelty, inventive step, and detailed disclosures that prevent ease of workaround.

  • Ongoing monitoring of related patents and patent laws in jurisdictions of interest is prudent for informed licensing, R&D decisions, or litigation.


FAQs

1. What is the significance of claim scope in patent JO3199?
The claim scope determines the extent of legal protection; broader claims cover more variations but risk invalidation if too encompassing, while narrower claims limit the scope but are often easier to defend.

2. How does the patent landscape affect the commercialization of JO3199?
Existing patents in similar areas can pose infringement risks or block entry. Conducting comprehensive patent clearance searches ensures freedom to operate and informs licensing or design-around strategies.

3. Can JO3199’s patent be extended or strengthened?
Yes. Filing related applications, such as divisional or continuation patents, can expand protection. Also, supplementary data demonstrating unexpected benefits can reinforce inventive step claims.

4. How does international patent protection impact the drug's market potential?
Securing patents in key jurisdictions prevents imitation and enhances licensing opportunities, enabling broader commercial reach and better return on R&D investments.

5. What are potential challenges facing JO3199’s patent validity?
Prior art disclosures, lack of inventive step, or overly broad claims can threaten validity. Regular patent landscape analyses and strategic prosecution help mitigate these risks.


References

[1] Jordan Patent Office Records, Patent JO3199.
[2] World Intellectual Property Organization (WIPO), Patent Cooperation Treaty (PCT) database.
[3] European Patent Office (EPO) Patent Data.
[4] U.S. Patent and Trademark Office (USPTO) Patent Full-Text and Image Database.
[5] Recent patent landscaping studies for pharmaceutical compounds.

Note: Specific filing and grant dates, experimental data, and claim details should be obtained from official patent documents for precise legal analysis.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.